These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25702849)

  • 21. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo.
    Ott DE; Hewes SM; Alvord WG; Henderson LE; Arthur LO
    Virology; 1998 Apr; 243(2):283-92. PubMed ID: 9568028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
    Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
    Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of a vaccine against feline immunodeficiency virus.
    Hosie MJ
    Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility in cell culture of feline immunodeficiency virus to eighteen antiviral agents.
    Smyth NR; McCracken C; Gaskell RM; Cameron JM; Coates JA; Gaskell CJ; Hart CA; Bennett M
    J Antimicrob Chemother; 1994 Oct; 34(4):589-94. PubMed ID: 7532645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
    Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
    J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.
    Mizukoshi F; Baba K; Goto Y; Setoguchi A; Fujino Y; Ohno K; Oishi S; Kodera Y; Fujii N; Tsujimoto H
    Vet Microbiol; 2009 Apr; 136(1-2):155-9. PubMed ID: 19036536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.
    Song W; Collisson EW; Li J; Wolf AM; Elder JH; Grant CK; Brown WC
    Virology; 1995 Jun; 209(2):390-9. PubMed ID: 7778274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the specificity of interaction of cellular and viral zinc-binding domains with 2-mercaptobenzamide thioesters.
    Jenkins LM; Durell SR; Maynard AT; Stahl SJ; Inman JK; Appella E; Legault P; Omichinski JG
    J Am Chem Soc; 2006 Sep; 128(36):11964-76. PubMed ID: 16953638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding Site.
    Long M; Cantrelle FX; Robert X; Boll E; Sierra N; Gouet P; Hanoulle X; Alvarez GI; Guillon C
    Biochemistry; 2021 Jun; 60(24):1896-1908. PubMed ID: 34096272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative investigation of the efficacy of two nucleocapsid analogs in FIV infected cats].
    Kuffer M; Balzarini J; Rolinski B; Goebel F; Erfle V; Goldberg M; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1997 Nov; 25(6):671-7. PubMed ID: 9459835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.
    Mori M; Kovalenko L; Lyonnais S; Antaki D; Torbett BE; Botta M; Mirambeau G; Mély Y
    Curr Top Microbiol Immunol; 2015; 389():53-92. PubMed ID: 25749978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy.
    Musah RA
    Curr Top Med Chem; 2004; 4(15):1605-22. PubMed ID: 15579099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaction Kinetics Direct a Rational Synthesis of an HIV-1 Inactivator of Nucleocapsid Protein 7 and Provide Mechanistic Insight into Cellular Metabolism and Antiviral Activity.
    Nikolayevskiy H; Scerba MT; Deschamps JR; Appella DH
    Chemistry; 2018 Jul; 24(38):9485-9489. PubMed ID: 29653024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel degradation product of 2,2'-dithiobis[N-isoleucylbenzamide], an inhibitor of HIV nucleocapsid protein zinc fingers.
    Phillips LR; Malspeis L; Tubbs EK; Supko JG
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):395-402. PubMed ID: 10933532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs.
    Casini A; Scozzafava A; Supuran CT
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):801-6. PubMed ID: 12426135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum to "Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection" [Bioorg. Med. Chem. 68 (2022) 116834].
    Laitinen T; Meili T; Koyioni M; Koutentis PA; Poso A; Hofmann-Lehmann R; Asquith CRM
    Bioorg Med Chem; 2022 Oct; 71():116948. PubMed ID: 35915023
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.
    Pery E; Sheehy A; Nebane NM; Brazier AJ; Misra V; Rajendran KS; Buhrlage SJ; Mankowski MK; Rasmussen L; White EL; Ptak RG; Gabuzda D
    J Biol Chem; 2015 Apr; 290(16):10504-17. PubMed ID: 25724652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.
    Ruffin N; Brezar V; Ayinde D; Lefebvre C; Schulze Zur Wiesch J; van Lunzen J; Bockhorn M; Schwartz O; Hocini H; Lelievre JD; Banchereau J; Levy Y; Seddiki N
    AIDS; 2015 Mar; 29(5):519-30. PubMed ID: 25715102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational challenges of structure-based approaches applied to HIV.
    Forli S; Olson AJ
    Curr Top Microbiol Immunol; 2015; 389():31-51. PubMed ID: 25711462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.
    Kaczmarek Michaels K; Natarajan M; Euler Z; Alter G; Viglianti G; Henderson AJ
    J Immunol; 2015 Apr; 194(7):3267-74. PubMed ID: 25710909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.